Where did the Union Ministry of Health and Family Welfare hold its Swachhata Hi Seva 2026 shramdaan?

The correct answer is 'Ek Din, Ek Ghanta, Ek Saath', which translates as one day, one hour, together. This is the theme under which the Swachhata Hi Seva 2026 campaign is being run across the country, and the spirit of joint action it stands for was what the Union Ministry of Health and Family Welfare echoed when its officers and staff joined a shramdaan in New Delhi on 1 October 2026. The theme puts a simple demand before every citizen: set aside one hour on a single day and work alongside others on cleanliness.

Option A, 'Swachhata Se Samriddhi', is not the theme of this campaign. Option C, 'Mera Shahar, Meri Zimmedari', is a plausible-sounding civic slogan but does not belong to Swachhata Hi Seva 2026 either. Option D, 'Ek Bharat, Swachh Bharat', mixes up the name of the wider Swachh Bharat effort, whose objectives the Ministry reaffirmed on the occasion, with the campaign theme, and so it is wrong as well.

The correct answer is Dr. Rajiv Bahl. He is Secretary of the Department of Health Research and also holds charge as Director General of the Indian Council of Medical Research, and he led the voluntary cleanliness drive held near Gate No. 3 of Kartavya Bhavan-1 on Dr. Rajendra Prasad Marg in New Delhi. Speaking to the media there, he said cleanliness must become a sustained collective effort and asked officials and citizens alike to contribute.

Option A, Dr. Rakesh Gupta, is Additional Secretary and Director General of the National AIDS Control Organisation; he took part in the drive but did not lead it. Option B, Smt. Aradhana Patnaik, is Additional Secretary and Mission Director of the National Health Mission, and she spoke on Jan Bhagidari and individual responsibility, again as a participant. Option D, Dr. Loveneesh G. Krishna, is the Director General of Health Services and was also among the participants.

The correct answer is the National AIDS Control Organisation, abbreviated NACO. Dr. Rakesh Gupta serves as Additional Secretary in the Union Ministry of Health and Family Welfare and as Director General of NACO, and in that capacity he was among the senior officers who joined the shramdaan in New Delhi.

Option A is wrong because the National Health Mission is headed, as Mission Director, by Smt. Aradhana Patnaik, who is also an Additional Secretary and who spoke at the event on the importance of people taking part. Option B is wrong because the Director General of the Indian Council of Medical Research is Dr. Rajiv Bahl, who is Secretary of the Department of Health Research as well and who led the drive. Option D is wrong because Dr. Loveneesh G. Krishna is the Director General of Health Services. All four officials attended, but only one of them heads NACO.

The correct answer is New Medicines, which took 27 of the 41 approved projects. Option B, Complex Generics and Biosimilars, accounted for five projects, so it is the smallest of the three real categories rather than the largest. Option C, Novel Medical Devices, accounted for nine projects, which places it second but still well behind New Medicines. Option D, clinical trial infrastructure, is not one of the priority areas named in the announcement at all, and it is included to test whether a candidate recognises the three-way split the department actually uses. The same announcement gives two other splits worth remembering: 12 projects are at an early stage against 29 at a later stage, and 19 belong to startups and MSMEs against 22 to large companies.

The correct answer is the Ministry of Chemicals and Fertilizers, which houses the Department of Pharmaceuticals, and it is that department which announced the approvals under PRIP. Option A, the Ministry of Health and Family Welfare, handles public health, hospitals and drug regulation through its own bodies, and candidates often place pharmaceuticals there by instinct, but the industrial promotion of the sector is not its charge. Option B, the Ministry of Science and Technology, funds research through its departments and is a reasonable guess for a research scheme, yet PRIP is not its programme. Option D, the Ministry of Commerce and Industry, deals with trade and industrial policy broadly rather than this scheme. Remember the pairing, since questions on drug price control, bulk drug parks and pharma production schemes all lead back to the same department.